NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
20/03/2026
Voltar para busca
Dado oficial do USPTO
PG2
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
21/03/2026
Tipo de marca
Mista
Classes Nice
5
Data de depósito
13/02/2015
Data de registro
13/09/2016
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/03/2026
Última transação
21/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
Taipei City, TW
Examinador
LOVELACE, JAMES B
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the characters "PG2" in a stylized format with a black outline around each character of the mark.
Titulares e representantes
Titulares
P. C. (pessoa física)
P. C. (pessoa física)
Representantes
Joe McKinney Muncy Muncy, Geissler, Olds & Lowe, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Traditional Chinese medicineherbal supplements; medicine for restoring blood cell counts and modulation of immunity; Traditional Chinese medicinal materialmedicinal herbs; pharmaceutical agents for the treatment of blood disorders; pharmaceutical agents for the treatment of the rare diseaseITP (Idiopathic Thrombocytopenic Purpura); medicine for human use for relieving cancer-related fatigue; nutritional supplements comprised of extracts from Astragalus membranaceus; biological preparations for preventing Chemotherapy Toxicities; chemico-pharmaceutical preparations for relieving cancer-related fatigue among cancer patients; adjuvants for enhancing white blood cellsRed blood cells and platelet counts recovery; pharmaceutical preparationsdrugs for the treatment of anemia; pharmaceutical preparations applied for Hemorrhagic Stroke and Acute Ischemic Stroke; medicated nutritional supplements; dietary supplements; nutritional supplements featuring antioxidants; nutritional supplements containing plant extracts from Astragalus membranaceus; herbal extract nutritional supplements
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
20/03/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
20/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/03/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
06/01/2026
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/01/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
06/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/01/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/01/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/01/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/09/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/01/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/01/2023
E815
TEAS SECTION 8 & 15 RECEIVED
27/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
13/09/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/06/2016
PUBO
PUBLISHED FOR OPPOSITION
28/06/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/06/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/05/2016
ALIE
ASSIGNED TO LIE
17/05/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/05/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/05/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
13/05/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/01/2016
GNFR
FINAL REFUSAL E-MAILED
06/01/2016
CNFR
FINAL REFUSAL WRITTEN
06/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2015
ALIE
ASSIGNED TO LIE
09/12/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/11/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/05/2015
GNRT
NON-FINAL ACTION E-MAILED
21/05/2015
CNRT
NON-FINAL ACTION WRITTEN
21/05/2015
DOCK
ASSIGNED TO EXAMINER
20/05/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
03/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2015
NWAP
NEW APPLICATION ENTERED
17/02/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PG2 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.